| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Lymphatica Medtech Lymph Flow Matters Lymphatica develops medical devices for treatment of lymphatic diseases. Born in 2017 as a spin-off of 2 leading Swiss universities, our first product is intended to bring a terrific improvement in quality of life for lymphedema patients: LymphoDrain, the first implantable artificial lymphatic vessels, is a medical device intended to recirculate lymph inside the patient body, re-establishing the physiological fluid equilibrium. Type: | 4 | 3 | 1 | 12 |
 |  Aerogabs Aerogabs is a consulting service for Entrepreneurs and Small & Medium Business. We boost your Company Performance by designing a Culture of Innovation. We have over 15 years of experience with a strong expertise in high-tech industries such as aerospace and medical devices. We offer 3 solutions: 1-Singularity - understands the dynamic of your territory and then adapt your posture in order to maximize your customer benefits. 2-Strategy - leverages your customer benefits by fully exploiting your potential and reducing the competitive threats. 3-Adocacy - assists you in the implementation of your actionnable plan to boost your venture performance. Please … Type: | 0 | 0 | 0 | 1 |
 | Polyneuron Pharmaceuticals AG Precision treatment of immune disorders Polyneuron is a growing Basel-based biotechnology company active in the area of autoimmune disease treatments. The company was founded in 2014 as a spinout company from the University of Basel to develop novel treatments to combat immune disorders using its Antibody-CatchTM technology platform. The company currently employs about 10 people and has raised a significant amount in equity funding from top-tier VCs. We are a team of passionate and experienced scientists, entrepreneurs and investors willing to bring new therapies to patients. Type: | 2 | 1 | 0 | 4 |
 |  Vicept Therapeutics, Inc Start-up Dermatology Company. Type: | 13 | 1 | 0 | 1 |
 | Dalan Animal Health, Inc. We bring the world transformative animal health solutions supporting a more sustainable future. Dalan's novel platform technology has introduced the world's first-ever honeybee vaccine, marking a pivotal milestone for the industry. Our mission is to safeguard the planet’s most underserved animal species, ensuring their continued well-being for global food security and the overall health of our planet. Type: | 1 | 0 | 1 | 24 |
 | Quantgene We bring life-saving genomics to hospitals, physicians and patients everywhere. Quantgene decentralizes genomics to bring precision medicine to everyone. Our turnkey genomics platform empowers hospitals to move life-saving genomic diagnostics inside their organizations, unlock powerful new sources of revenue and become a driving force in clinical discovery. From complete genomic profiling to hereditary cancer testing and multi-cancer early detection, we help hospitals, physicians and patients to unlock the full power of precision genomics. Cancer diagnostics, biotechnology, genomics, machine learning, oncology, precision medicine, cancer screening, deep sequencing, cancer, innovation, AI, and Cancer Detection Type: | 4 | 0 | 4 | 39 |
 | VectivBio AG Life-Transforming Medicines for Patients Living with Serious Rare Diseases VectivBio AG is a clinical-stage biotechnology company focused on rare diseases with a well-defined biology that can be targeted with transformational therapeutics. VectivBio was formed in 2019 as a spinout from Therachon, a biotechnology company acquired by Pfizer, Inc., for its program in achondroplasia, with the ambition to continue to have an impact on people’s lives by bringing transformational medicines to patients with serious rare conditions. The company is led by a world-class leadership team with deep expertise in rare diseases and a track record of success in R&D, commercialization and … Type: | 2 | 0 | 1 | 57 |
 | eXmoor Pharma eXmoor is a full service Cell & Gene Therapy CDMO, backed by over 20 years manufacturing experience for 150+ clients eXmoor is a full service Cell & Gene Therapy CDMO with a difference. We are backed by 20 years consultancy experience supporting over 150 organisations accelerate novel therapies from discovery to patients. We provide expert solutions at all stages of the development journey from early process development and scale-up through to GMP manufacture, fill and finish and QP release. We are open, transparent and will work with you at every step to de-risk and streamline your project and maximise the … Type: | 1 | 0 | 1 | 78 |
 | OxyNov Revolutionizing oxygen therapy with the FreeO2: a device that optimizes every stage of treatment during hospital care. We are and want to remain pioneers in offering powerful, innovative, and cutting-edge technologies to oxygen therapy care. Our mission is to overcome the current limitations of respiratory care and oxygen therapy to : - Improve the safety and quality of life of patients. - Optimize care in a context of increasing number of patients and of hospitalization cost control. Our flagship device, the FreeO2, an automated oxygen therapy system : - Adjusts oxygen flow to the patient's needs in real time, avoiding … Type: | 3 | 1 | 1 | 15 |
 | Addex Therapeutics Allosteric modulators for Human Health Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators for neurological disorders. Allosteric modulators offer several potential advantages over conventional non-allosteric molecules and may offer an improved therapeutic approach to conventional "orthosteric" small molecule or biological drugs. Addex's allosteric modulator drug discovery platform targets receptors and other proteins that are recognized as essential for therapeutic intervention. Addex's lead drug candidate, dipraglurant (mGlu5 negative allosteric modulator or NAM), is poised to start a pivotal registration clinical trial … Type: | 3 | 0 | 3 | 18 |
 |  Bioretec Ltd. better healing - better life Bioretec Ltd. is a medical device company focusing on the development of strong, safe and reliable bioabsorbable and bioresorbable implants for pediatric and adult orthopaedics. Our products are used worldwide, and we continue to further develop materials and products for load-bearing clinical applications. biomaterials, medical, manufacturing, medical devices, implants, absorbable metal, biopolymers, orthopaedics, and pediatric surgery Type: | 0 | 0 | 0 | 43 |
 | Novostia Heart valves for life, for patients of any age, including children Novostia is a privately held medical device company developing an innovative artificial heart valve, designed for patients of any age, including children. Novostia endeavors to advance its technology to clinical trials and regulatory approvals to improve the quality of life of millions of people worldwide suffering from aortic and mitral valve disease. For more information please visite www.novostia.com Heart Valves and Medical Devices Type: | 0 | 0 | 0 | 16 |
 | BÜHLMANN Laboratories AG BÜHLMANN is a fully independent, medium sized and family owned Swiss company. Founded in 1976, BÜHLMANN today has local teams in Switzerland, France, Italy, Germany, Austria, USA and Brazil and distributors worldwide. BÜHLMANN has become the prime calprotectin company within few years, offering the broadest range of calprotectin assays from fully automatable, high-throughput turbidimetric and ELISA assays, BÜHLMANN fCAL® turbo and BÜHLMANN fCAL® ELISA, to the point-of-care quantitative Quantum Blue® and IBDoc® home test application. Additional to calprotectin assays, BÜHLMANN offers therapeutic drug monitioring solutions for biologics used in chronic inflammatory diseases. BÜHLMANN does not only stand for calprotectin, but … Type: | 0 | 0 | 0 | 114 |
 | SeeO2 Energy Inc. Fuels and chemicals from CO2 SeeO2 Energy Inc. vision is to efficiently convert captured CO2 and/or water to fuels and chemicals using reversible solid oxide fuel cell technology. We provide our customers in the chemicals, metal processing, polymers, and utilities industries with a reliable, onsite and cost competitive industrial feedstocks for their products. ELECTROCHEMISTRY, Solid Oxide Fuel Cells, Solid Oxide Electrolysis Cells, Power to Gas, CO2 to Fuels, Reversible Fuel Cells, Electrolysers, Power to fuels, H2O electrolysis, CO2 electrolysis, and CO2 utilization Type: | 2 | 1 | 1 | 5 |
 | Diatech Pharmacogenetics Leader in the development, production and sales of pharmacogenetics tests for cancer precision medicine. Diatech Pharmacogenetics, the leading Italian Precision Medicine company. Diatech Pharmacogenetics is a provider of molecular diagnostic tools for precision medicine. The company aims at simplifying complex molecular diagnostic procedures into easy end-to-end solutions, from nucleic acids extraction and their molecular analysis, to final reporting. The company has 10 years of experience in the successful implementation of several nucleic acid analysis technologies into regulated diagnostic pipelines; examples include pyrosequencing, mass spectrometry and digital molecular barcoding. Leading cancer centres in Italy and abroad rely on Diatech CE-IVD solutions … Type: | 3 | 1 | 1 | 62 |
 | Sus Clinicals, Inc. Enabling our healthcare client partners to accelerate breakthrough cancer solutions. Sus Clinicals solves major problems in qualifying new cancer drugs, devices, diagnostics and therapies. Using a proprietary model of testing on genetically-modified pigs pioneered at the University of Illinois, Sus Clinicals leverages the inherent advantages of a patent-pending large animal testing methodology combined with novel clinical approaches to reduce false positives, model the interactions of multiple diseases, and accelerate progress toward human trials for the most promising therapies. Type: | 0 | 0 | 0 | 17 |
 | WINPRO Pet Harnessing The Power Of Clinically Proven Blood Proteins To Help Your Dog Stay Healthy, Active, And With You. WINPRO is the world's first and only line of blood protein supplements. WINPRO products use the power of clinically proven animal blood proteins to help prevent and combat the negative effects of stress-induced inflammation in dogs. Many of today's most common canine health problems are caused by inflammation which is often caused by stress. Type: | 0 | 0 | 0 | 5 |
 | ELIAS Animal Health Changing the way cancer is fundamentally treated. ELIAS Animal Health is elevating the hope of veterinarians and pet owners alike by changing the way cancer is fundamentally treated. Our approach is profoundly simple: Every canine patient is unique. Every cancer is unique. To ultimately win against this devastating killer, cancer therapy itself must also be unique. The ELIAS Cancer Immunotherapy (ECI®) works by conditioning the immune system to recognize a patient’s unique cancer, and then delivering an army of activated killer T cells to specifically target and attack those cancer cells. Learn more at eliasanimalhealth.com. Type: | 0 | 0 | 0 | 10 |
 | Loyal Loyal is developing the first-ever drugs intended to extend the healthspan and lifespan of dogs. Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the lifespan and healthspan of dogs. In other words, our mission is to help dogs live longer, healthier lives. We’ve already achieved significant milestones on our path to gaining FDA approval for the first lifespan extension drug for any species. We have three products in our pipeline and expect to bring the first product to market in 2025. Our team includes scientists, veterinarians, engineers, operators, and creatives. Join us in our mission to … Type: | 0 | 0 | 0 | 201 |
 | Microbiologics The world's go-to partners for infectious disease biomaterials and testing services. We are the world’s leading experts and go-to collaborators in biological products and services, focused on protecting the health and safety of people around the world. For over 50 years, we have been partnering with healthcare and life science laboratories, manufacturers and suppliers across the globe to co-create and provide biological control materials, assay services and consulting for microbiology, molecular diagnostics and virology. Headquartered in Saint Cloud, Minnesota, we have additional facilities in California, Kentucky and Michigan. Microbiology, Biotechnology, Quality Control, Molecular Microbiology, Contract Research Organization, Virology, Anti-Infective Drug … Type: | 1 | 0 | 2 | 351 |
 | Pinney Associates, Inc. Guiding Pharmaceutical and Consumer Healthcare Companies to Success Pharmaceutical and consumer healthcare companies work within dynamic, sometimes unpredictable, regulatory and commercial environments. Pinney Associates' multidisciplinary teams anticipate your scientific and policy obstacles while guiding you toward regulatory and marketplace success. Pharmaceuticals, Risk Management, Abuse Liability Testing, Rx to OTC Switch, In vitro, Abuse potential assessment, Consumer healthcare, Consumer insights, Business development, FDA, CNS active drugs, Regulatory, Over-the-counter medicines, OTCs, Nonprescription drugs, Dietary supplements, Regulatory Strategy, Clinical Development, Eight Factor Analysis 8FA, Abuse Deterrent Formulation Evaluation, Postmarketing Surveillance, Risk Evaluation and Mitigation Strategies, REMS, Target Product Profiles, Scientific Assessment and Review, … Type: | 4 | 0 | 4 | 28 |
 | CONMED Foot & Ankle A Division of CONMED Corporation CONMED Foot & Ankle proudly offers surgeons a comprehensive portfolio of tailored and simplified solutions for foot and ankle procedures. We specialize in designing and manufacturing unique products to address unmet clinical needs and improve surgical outcomes and patient care. We are proud to be forerunners in developing solutions for sterile implants and single-use instrumentation. For more information, or if you wish to be contacted, please visit www.conmed.com/footandankle. Foot and Ankle , Medical Device, Small Joint Implants, Nitinol Staples, Plates, Cannulated Bone Screws, Sterile Portfolio , Orthopedics, Extremities, Ankle, Bunion, and Lapidus Type: | 0 | 0 | 0 | 70 |
 | RTI Health Solutions Providing the trusted research and strategic planning services you need for your drug or medical device. RTI Health Solutions' integrated project teams are here to help you with your pharmaceutical and medical device research needs. Our robust and trusted methods provide answers to the research questions relevant to your drug or device. Our experienced teams are with you throughout your product's lifecycle to ensure you have the evidence you need when you need it. They continuously monitor your portfolio of projects to keep them flowing seamlessly—enabling you to focus your time elsewhere. Follow us @RTIHS on Twitter too. We are … Type: | 2 | 0 | 2 | 369 |
 | Coridea Global Medical Device Incubator with specialty in Cardiac, Pulmonary, and Renal Innovation INNOVATION Coridea is a premier medical device incubator driven by an innovative and translational health care approach. Coridea develops unexpected device solutions that change the lives of cardiology, pulmonary and renal patients who have no other treatment options. INVENTION Coridea is a leading inventor in the medical device arena and has a proven track record of generating innovative technology and converting it into high impact solutions for patients and high value returns for investors. SUCCESS Coridea has successfully launched six cardiology and renal focused companies in the past … Type: | 0 | 0 | 0 | 9 |
 | Ra Medical Systems Our Mission: Save lives, limbs and improve patients’ quality of life. Ra Medical Systems was founded in 2002 to design, develop, and commercialize excimer lasers as tools for the treatment of vascular and dermatological diseases. Pharos excimer laser system was launched in October 2004 and was used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. The company sold these dermatological products and services in August 2021 to focus solely on the larger vascular business opportunity. In May 2017, the DABRA laser and single-use catheter (together “DABRA”) received FDA 510(k) clearance in the U.S. for crossing … Type: | 2 | 2 | 0 | 38 |
 | MaxCyte, Inc. Let's Build Better Cells Together We invest in our partners early on, working side by side in optimizing their processes to derisk their path to the clinic faster. Our ExPERTTM platform, which is based on our Flow Electroporation® technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATxTM, STxTM, GTxTM and VLx TM; a portfolio of proprietary related processing assemblies or disposables; and software protocols, … Type: | 4 | 1 | 2 | 141 |
 | Laboratorios Syva Soluciones con Sentido para la Salud Animal - Meaningful Solutions for Animal Health Our mission is to provide efficient solutions for the permanent improvement of animal health, creating value for the client through the commitment and capacity of our human team. Laboratorios Syva researches, develops, manufactures and commercializes biological and pharmaceutical products for the veterinary sector, with own subsidiaries in Spain, Portugal and Mexico, and a presence in more than 70 countries worldwide through a network of business partners and distributors. Veterinary biologicals, Veterinary pharmaceuticals, Veterinary antimicrobials, Vaccines, Bienestar animal, CMO, Contract manufacturing, and R&D Type: | 1 | 0 | 1 | 252 |
 | Nikon Instruments Nikon Instruments is the Microscope division of Nikon Healthcare and a leader in optical and imaging technologies. Nikon Instruments Inc. is a leading provider of microscopes, cameras, and related technologies for the clinical, educational, research, biotech, and other markets. With over 100 years of optical experience, Nikon is a global leader with a long history of innovation that continues to set the standard for quality and reliability. Nikon Instruments Inc. belongs to the Nikon Corporation Healthcare Business Unit, whose mission is to advance healthcare and provide a better quality of life while promoting creativity and trustworthiness. Nikon remains the only … Type: | 2 | 0 | 1 | 502 |
 | BINDER GmbH Best conditions for your success --- BINDER - Best conditions for your success The world's largest specialist in simulation chambers for the scientific and industrial laboratory. Whether cold testing, heat testing, stress testing, stability testing or drying paint, when developing our products we have but one goal: to provide the perfect solution for exactly your area of application in the scientific and industrial laboratory. Clients include: Bayer, BASF, Novartis, Aventis, Schering Plough, Max Planck Institute, Bayer Pharma, Byk Gulden, Boehringer Ingelheim, DKFZ, Daimler, Bosch, Siemens, Toyota, Philip Morris, Kraft Food, Nestlé and many more! Microbiological Incubators and Heating Ovens for … Type: | 1 | 0 | 0 | 232 |
 | Gilson Gilson provides high quality, dependable solutions for today's demanding liquid chromatography, solid phase extraction, liquid handling and gel permeation chromatography clean-up requirements. From the legendary PIPETMAN® products to a full range of system solutions, Gilson is the element of purification for your laboratory. Gilson has worldwide sales and service supporting the pharmaceutical, biotech, environmental, clinical, food & beverage and forensic markets. Our primary focus is on purifying samples via preparative HPLC, automated SPE or through GPC clean-up. Gilson focuses on early drug discovery and development with our preparative HPLC systems. Gilson's automated SPE systems and GPC clean-up systems support environmental, … Type: | 4 | 3 | 0 | 488 |
 | APC Europe Global Leader in Functional Proteins - Helping Animals Thrive 📣 Who is APC Europe? We are the world’s largest manufacturer of Spray-Dried Plasma, Hydrolyzed Proteins and other High-Quality Proteins. Our main goal is researching and producing feed ingredients with the best quality to enhance health and animal nutrition. APC Europe is part of the LGI Group and subsidiary of APC Inc. -Ankeny (Iowa). 🔧 What APC Europe does? At APC, we market, research and develop products principally derived from blood proteins based on customer need. We efficiently procure and manufacture safe and effective products for use in animal, with a … Type: | 2 | 1 | 1 | 67 |
 | Dômes Pharma US Sentrx Animal Care, Inc. is now a part of Dômes Pharma Group. Dômes Pharma, an independent family-owned group, a pioneer in animal health, has been developing, manufacturing and marketing solutions for the health and well-being of pets since 1947. Established in Auvergne in central France, the region of volcanoes and its domes from which it takes its name, in 2016 the Group began its international expansion by opening subsidiaries in the UK, Germany, Spain and the USA. In July 2023, the Group acquired the American company Sentrx Animal Care based in Salt Lake City (Utah), which develops and manufactures ophthalmology … Type: | 1 | 0 | 0 | 14 |
 | Destiny Pharma Limited Infection prevention biotech with late-stage assets targeting C. difficile and post-surgical S. aureus infections Destiny Pharma is a clinical stage, innovative biotechnology company focused on the development of novel medicines that can prevent life-threatening infections. Its pipeline has novel microbiome-based biotherapeutics and XF drug clinical assets including NTCD-M3, a Phase 3 ready treatment for the prevention of C. difficile infection (CDI) recurrence which is the leading cause of hospital acquired infection in the US and also XF-73 nasal gel, which has recently completed a positive Phase 2b clinical trial targeting the prevention of post-surgical staphylococcal hospital infections including MRSA. It … Type: | 1 | 0 | 1 | 24 |
 | SolasCure Transforming chronic wound care with a breakthrough wound therapeutic Chronic wounds affect ~100m people around the world, impacting quality of life & placing a huge burden on health systems. Despite the many innovations in wound care over the years, chronic wound healing rates have barely improved. Change is needed – patients, practitioners, and regulators across the industry are in urgent need of high-impact innovations in chronic wound care. SolasCure is at the forefront of addressing this demand, aiming to shift the current treatment paradigm with a high impact therapeutic approach to debridement, with the goal of enabling dramatic improvements in … Type: | 2 | 1 | 1 | 17 |
 | ADC Therapeutics Innovating Science. Inspiring Hope. ADC Therapeutics is a commercial-stage global pioneer in the field of antibody drug conjugates (ADCs). Our goal is to be a leading ADC company that transforms the lives of those impacted by cancer. To achieve this, we are focused on unlocking the potential value of our robust ADC portfolio across two pillars of growth: hematology and solid tumors. We are a pioneer in the ADC field with specialized end-to-end capabilities unique to ADCs including a validated technology platform, a growing next-generation research & development toolbox and a proven track record that includes an approved and marketed … Type: | 2 | 0 | 2 | 307 |
 | PROTEROS biostructures GmbH REACH RIGHT FASTER Proteros is a privately held early-stage services provider in structure-based drug discovery with a cutting-edge discovery engine tailored to unlock even the most technically challenging targets. Proteros’ work is built on scientific excellence and supports its clients to reach the right results and accelerate their overall research timelines. Proteros supports most of the world’s 20 largest pharma companies and more than 250 pharmaceutical and biotech partners in the US, Europe and Japan. For more information please visit www.proteros.com. As we continue to grow, we constantly look for committed, professional and energetic people with a high sense of … Type: | 2 | 0 | 2 | 135 |
 | PMSm [Automatic translation follows] Medical assistance in the workplace / Outsourcing of company nurses / Biomedical engineering A French leader in medical assistance in industrial and tertiary environments, PmSm is a structure dedicated to providing medical services. * Outsourcing of company nurses * Emergency medical assistance: sites open to the public, construction sites, technical shutdowns, industrial sites, medical centers in isolated environments or in hostile environmental conditions; etc. * Support for drug and alcohol prevention policies * Biomedical engineering (supply and maintenance of medical devices) PmSm recruits nurses and doctors on permanent contracts who are seconded to client companies. It offers … Type: | 12 | 1 | 11 | 272 |
 | Biose Industrie Founded in 1951 by pharmacists and microbiologists, biose® has 60-year experience in drug based on live bacteria, giving us a deep understanding of the entire process from discovery to commercialization. Focused on Health through microbiota and microbiome science, we use our skills for the discovery, product development, clinical studies and manufacturing of Live Biotherapeutic Products (LBPs). Our company is drug-GMP certified for the manufacturing of bacteria-based APIs, clinical and commercial products. Microbiome Therapeutics, live biotherapeutics, LBPs, and CDMO Type: | 10 | 5 | 3 | 226 |
 | Anthogyr French creator of cutting-edge implantology solutions. About ANTHOGYR With more than 75 years of industrial expertise and experience in the dental industry, Anthogyr designs and manufactures ingenious and accessible solutions in implantology and customised prostheses for dentistes and dental laboratories. Recognised for its high quality products, Anthogyr offers the following: - implants system Axiom® Multi Level®, screw retained tooth AxIN® - customized prosthesis (digital & CAD/CAM solutions Simeda®, Initial®, guided surgery) - equipment for implantology and surgery Mont Blanc® - implantology trainings, CAMPUS Anthogyr - patient communication tools - Serenity® warranty program Both innovative and reactive, Anthogyr assists implantologists in … Type: | 5 | 2 | 5 | 251 |
 | Vexim is now a part of Stryker Based in Balma, near Toulouse (France), Vexim is a medical device company created in February 2006. The Company has specialized in the creation and marketing of minimally-invasive solutions for treating traumatic spinal pathologies. Benefitting from the financial support of it longstanding shareholder, Truffle Capital and from OSEO public subsidies, Vexim has designed and developed the SpineJack®, an implant for the reduction of mobile spinal fractures and restoration of the balance of the spinal column. The Company currently has 65 members on its staff and it has its own sales teams in France, Germany, Austria, Italy, Spain, as well as distributors … Type: | 0 | 0 | 0 | 11 |
 | PhysioStim Nonclinical expert in cardiovascular pharmacology & electrophysiology and vascular functions PhysioStim is a French preclinical CRO dedicated to cardiovascular pharmacology and electrophysiology from discovery stages to clinical development. Whatever the therapeutic areas, we ensure robust and valuable preclinical data on cardiac and vascular activities and secondary pharmacology to secure in-vivo development and bring new safe therapies to patients. Thanks to our predictive and translational models, we define the POC of drug discovery, we investigate secondary pharmacology with on and off-target liabilities, and we address the safety purpose to build and support your IND submission (with mandatory and not mandatory assays). … Type: | 1 | 0 | 1 | 10 |
 | Novalix Novalix is a premier drug discovery CRO Novalix is a premier drug discovery partner to biotech firms and pharmaceutical companies. We apply our exceptional scientific talent and exclusive resources across our platforms to improve the odds of success at each critical pre-clinical stage. The better the science, the better the outcomes. For additional information visit www.novalix.com Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand co-crystal structures by XRD, Native mass spectrometry, FBDD, Organic Chemistry, cryo-electron microscopy, Chemical development, Medicinal chemistry, Structural Biology, in vitro pharmacology, DNA-encoded libraries, Flow chemistry, and Chemical process research Type: | 31 | 6 | 27 | 386 |
 | Clean Cells Solution for biologics Clean Cells is a GMP-licensed Contract Development and Manufacturing Organization providing R&D, production and quality control testing services to the biopharmaceutical industry. Our two-part site located in Western France holds an innovative process development platform, BSL2 and BSL3 GMP manufacturing laboratories and analytical areas to develop bespoke assays and perform GMP testing. Clean Cells is part of the Clean Biologics group and benefits from the additional experience of sister company Naobios, a CDMO with considerable experience in the development and manufacture of virus-based products. biosafety testing, Cell Banking and Storage, Viral Clearance, Potency Assay, R&D Contract, Training, … Type: | 9 | 3 | 7 | 126 |
 | ELICITYL Glycans & Glycoconjugates expertise Elicityl is a biotechnology company based near Grenoble France within one of the largest research clusters in Glycosciences in the world. 👉🏻 Elicityl is specialized in carbohydrates design & manufacturing and has unique expertise in extraction, purification, bacterial fermentation, characterization, and analysis of carbohydrates. Our catalog of products, which is constantly evolving, includes: ✅ 200 glycans involved in key biological pathways (Cell adhesion, Immunological recognition, Embryogenesis, Oncogenesis, Infection...) ✅ Analytical references (HMOs, Malto-Oligosaccharides, Fructo-Oligosaccharides...) ✅ Polysaccharides extracted from biomass (Alginate, Ulvan, Pustulan...) ✅ Functionalized glycans ✅ Glycoconjugates ✅ Lectins We supply materials from the mg scale … Type: | 4 | 1 | 3 | 14 |
 | GENCLIS SA The Transcription Infidelity Technology GENCLIS SA is a privately-held French Biotechnology that discovered a unique biological mechanism referred as to Transcription Infidelity (TI). Transcription Infidelity is a newly discovered and patented mechanism that incresases RNA-DNA sequence divergences (RDD). TI can lead to base substitutions, insertions and deletions. The latter cause translational frameshifts that have important consequences in determining protein immunogenicity. Genclis currently focuses on defining the effects of TI proteins translated from gapped RNA on normal and pathological humoral immunity. Type: | 0 | 0 | 0 | 6 |
 | Provepharm Act to improve life An independent, international specialty pharmaceutical company, Provepharm leverages the potential of mature and well-known molecules to develop innovative solutions that improve patients' lives. Provepharm develops, manufactures, and markets a range of hospital products including antidotes and dyes. Notably, the company is recognized for its expertise in the endoscopic and surgical dye markets. Working closely with healthcare professionals, Provepharm is committed to developing specific services aimed at helping them enhance clinical practices. With a team of over 160 professionals and offices in France, the US and UK, the company markets its products in over 25 countries worldwide … Type: | 7 | 5 | 2 | 156 |
 | Aureus Pharma Aureus Sciences focuses on providing solutions to the needs of pharmaceutical and biotech companies to leverage information and knowledge as a decision making tool and to increase the speed and efficiency of their drug discovery and development process. Over the course of 10 years and with a significant investment, the Company has developed a unique Knowledge Production Platform which analyzes, indexes and organizes critical chemical and bioactivity information into databases. Using this platform the Company provides best-in-class, scientific databases and associated software applications for use by researcher involved in the drug discovery and development process.The company's range of products includes … Type: | 0 | 0 | 0 | 1 |
 | SYNCROSOME - Cardiovascular Preclinical expert Cardiovascular & respiratory preclinical expertise since 2000 - ETAP-Lab's cardiology branch of services. At a glimpse SYNCROSOME is the cardiology branch of ETAP-Lab, French preclinical CRO dedicated to in vitro & in vivo efficacy studies for pharmaceutical & biotech companies for over 30 years. Range of services SYNCROSOME is dedicated to cardiovascular & respiratory diseases models like HFrEF, HFpEF, acute myocardial ischemia and arterial/pulmonary arterial hypertension... Models in cardiometabolic disorders are also available. Our added value We can accelerate, derisk and support preclinical development of therapeutics thanks to relevant & translatable in vitro and in vivo models. Our experts aim … Type: | 2 | 2 | 1 | 9 |
 | Genoscience Pharma Innovating to Disrupt Cancer Treatment Genoscience Pharma is a French biotech company developing unique small molecules in Oncology. This is the first clinical stage company ever with unique lysosomotropic agents assessed in global clinical trials. For more information, please visit our website, or call us +33 4 91 26 99 50. Liver, Oncology, Clinical Development, Preclinical Development, Discovery, Research & Development, Intellectual Property, Drug Development, and Small Molecule Type: | 6 | 2 | 4 | 5 |
 | BioFeyn BioFeyn is a life sciences company, pioneering advancements in nutrient, medicine, and vaccine delivery to improve food systems and sustainability. Type: | 6 | 0 | 5 | 3 |
 | XenTech Premium quality preclinical oncology CRO, pioneering the PDX technology for more than 16 years. XenTech is Biotech/Contract Research Organization (CRO) dedicated to translational research in oncology which offers preclinical services to evaluate the anti-cancer potential of drug candidates (PDX, CDX,...) In addition, XenTech develops internal R&D programs to correlate drug response with molecular features of tumors and identify cancer biomarkers and therapeutic targets. patient-derived tumor xenograft models, oncology, biomarkers, efficacy preclinical studies, PDX, CDX, in vivo, and in-vitro assays Type: | 4 | 2 | 4 | 37 |
 | Medicrea Pioneering the digital transformation of spinal surgery through A.I., predictive modeling and patient-specific implants. Through the lens of predictive medicine, MEDICREA® leverages its proprietary software analysis tools with big data and machine learning technologies supported by an expansive collection of clinical and scientific data. The Company is well-placed to streamline the efficiency of spinal care, reduce procedural complications and limit time spent in the operating room. Operating in a $10 billion marketplace, MEDICREA® is a Small and Medium sized Enterprise (SME) with 210 employees worldwide, which includes 50 who are based in the U.S. The Company has an ultra-modern manufacturing … Type: | 1 | 1 | 0 | 68 |
 | Mewery The first European startup cultivating pork meat on a proprietary microalgae base Mewery is the first European foodtech startup developing cultivated pork on microalgae base. Thanks to Mewery, people all over Europe, Asia and further will be able to enjoy real pork meat, juicy and healthy, but with one huge difference: without having to kill a single pig or harming the planet. Mewery is using their own hybrid culture medium with microalgae extracts and developing 3D structures on microalgae scaffolds. pork cell lines, culture media, proprietary growth factors, microalgea expertise, cultivated pork product line, cellular agrculture, and cell-based meat Type: | 4 | 2 | 2 | 8 |
 | GlycoEra AG Advancing Glycan Mediated Therapy GlycoEra is positioned as the leading precision protein degradation company. Bifunctional biologics (G-LyTACs), designed by our novel and proprietary technology bind to disease-causing proteins and transport them to the lysosome using naturally occurring endocytic receptors. The disease-causing proteins are degraded in the lysosome and removed from the body. Unlike intracellular protein degraders, like PROTACs and molecular glues, our technology can access targets that are extracellular and membrane proteins, thereby opening up novel targets and therapeutic areas for intervention. Glycoengineering, Therapeutic product development, and Biopharmaceutical CMC development Type: | 1 | 0 | 1 | 37 |
 | RIBOPRO Dream ahead. RIBOPRO is an innovative service provider, producing high-quality, high-performance RNA products, which are used as powerful research tools and therapeutics. RiboPro offers both off-the-shelf and custom RNA products at competitive rates and turn-around times, effectively removing all barriers to successful use of RNA in the research and development of our customers. We have more than 2 years experience satisfying the RNA-related needs of our (returning!) customers and thus we are confident that we can help you get your next project off to a good start. Let us worry about the quality and performance of your RNA, so you … Type: | 0 | 0 | 0 | 30 |
 | Tempty Foods Foods of the future based on mycelium (fermented "roots of mushrooms"). 🍄🟫🌱 We are a Danish food innovation company, creating the foods of the future based on mycoprotein (fungi). 🌱🍄 Our first product, TEMPTY, is the next-generation food ingredient offering a great taste experience instead of imitating meat. TEMPTY is made of mycoprotein from fungi, the secret behind the exceptional texture and delicate umami flavor of our products. 🍄 In Tempty Foods, we are on a mission to bring sustainable innovation to everyone’s plates! 🌍 Stay tempted, more products are coming! Food innovation, Mycoprotein, Alternatives to meat, Green proteins, and … Type: | 1 | 1 | 0 | 6 |
 | Sylvia Health A simple and effective way for every woman to manage pelvic organ prolapse Sylvia Health is actively developing a non-surgical solution for pelvic organ prolapse, a condition impacting 8% of all women. Existing treatment options are inadequate. Surgery is painful and too often ineffective, whereas pessaries are abandoned by half of users within a year. Guided by the ongoing input of women, Sylvia’s solution is meticulously crafted for precise support and ease of use, empowering women to reclaim their quality of life. Connect with us, explore our page, and visit our website (link below) to stay informed about our journey … Type: | 0 | 0 | 0 | 2 |
 | EVERSENS SL What you breath reveals We develop innovative solutions based on the analysis of exhaled biomarkers as useful tools for the diagnosis, prognosis, and monitoring of various respiratory diseases, among which asthma stands out. We currently have the evernoa BASE device, which allows to measure airway inflammation by detecting Nitric Oxide through a simple and non-invasive test. I+D, Biomarcadores exhalados, Óxido Nítrico, Fabricación, Comercialización, ISO13485, Dispositivos Médicos, Patentes, eHealth, R&D, Exhaled Biomarkers, Nitric Oxide, Manufacturing, Commercialization, Medical Devices, Patents, FeNO, and Asthma diagnostic and management Type: | 7 | 0 | 0 | 10 |
 | Bioceltix Bioceltix is changing the veterinary therapy standards. We develop innovative biopharmaceuticals based on stem cells. Bioceltix is a biotech start-up which deals with the development of stem cell-based medicinal products for veterinary use. Currently, our main goal is to implement a biopharmaceuticals based on allogenic stem cells. The medicines will be primarily to serve the treatment of accompanying animals. The new product candidates will become a milestone in the field of stem cell-based biopharmaceuticals for veterinary use. As one of the first such Europe-based company, Bioceltix product intends to go through the full registration path to a marketed drugs devised … Type: | 0 | 0 | 0 | 27 |
 | Formycon AG The Biosimilar Experts Who we are Formycon is a leading, independent developer of high-quality biopharmaceutical medicines, especially biosimilars. The company focuses on treatments in ophthalmology, immunology and on other key chronic diseases, covering the entire value chain from technical development to the clinical phase III as well as the preparation of dossiers for marketing approval. With its biosimilars, Formycon is making a major contribution towards providing as many patients as possible with access to vital and affordable medicines. Formycon currently has four biosimilars in development. Based on its extensive experience in the development of biopharmaceutical drugs, the company is also … Type: | 2 | 0 | 2 | 180 |
 | CellVoyant We see the future in cells CellVoyant is an AI-first biotechnology company with a mission to create novel stem cell-based therapies for chronic diseases. Our technology uses AI-first live cell imaging to predict and optimise stem cell differentiation, to controllably manufacture any cell and tissue in the body at scale. CellVoyant is built on foundational work from the Carazo Salas lab at the University of Bristol. We’re working at the exciting intersection of cell biology, computer vision, engineering, and machine learning to industrialise next-generation science from research into the real world. Our mission is bold and ambitious and we have … Type: | 3 | 0 | 3 | 15 |
 | AFFIRMA BIOTECH SL Affirma Biotech develops new products to overcome the challenge of Multi Drug Resistant and Chronic Infections Affirma Biotech is a start-up company specialized in the discovery and development of new anti-infective drugs via immunomodulation. Type: | 0 | 0 | 0 | 5 |
 | VICO Therapeutics B.V. Our mission is simple... bring innovative RNA modulating therapies to patients with severe, genetic neurological diseases. Vico Therapeutics is committed to advancing RNA modulating therapies for patients with severe, genetic neurological disorders. Vico is initially targeting spinocerebellar ataxia types 3 and 1 and Huntington’s disease. Our VICOMER platform designs antisense oligonucleotides for various genetic defects by modulating or editing RNA. For more information, visit www.vicotx.com Type: | 0 | 0 | 0 | 40 |
 | DISCO Pharmaceuticals GmbH The surfaceome company. DISCO’s pioneering surfaceome mapping platform transforms the current approach of target discovery for large molecule R&D. The technology identifies proteins and protein communities across the entire cancer cell surface in a scalable manner, thus addressing the need for target candidates for both mono- and bi-specific antibodies. These insights enable the development of a multitude of cancer-selective therapies, with the potential to boost efficacy and reducing side effects for patients. Type: | 1 | 1 | 0 | 24 |
 | Calluna Pharma Developing first-in-class therapies designed to defeat chronic inflammation and fibrosis at the source. Our innovative therapeutic approach targets upstream amplifiers of disease offering potential treatments across a diverse array of therapeutic indications. Calluna Pharma is a clinical stage biotech company driven by a commitment to improve patient outcomes in diseases where existing treatments are sub-optimal. We believe in the power of immunology to push boundaries, challenge the status quo, and develop therapies that will make a real difference for people living with serious diseases. Type: | 0 | 0 | 0 | 12 |
 | Carcinotech Ltd Reinventing Cancer Research Carcinotech has pioneered the development of assay-ready, 3D-bioprinted tumours derived from patient biopsies for oncology drug discovery and development. Carcinotech’s tumours are uniquely engineered to preserve cancer heterogeneity by encompassing multiple cell types present in the donor tumour microenvironment, including cancer, stromal, specialized microenvironment, immune, and cancer stem cells. This physiologically and genetically relevant model offers superior predictive power compared to traditional organoid and animal models, improving drug discovery, optimization, and pre-clinical testing efficiencies, thereby shortening the path to bringing a new oncology therapy to market. Precision oncology, Cancer research, 3D bioprinting , Drug discovery , Cancer … Type: | 2 | 0 | 1 | 19 |
 | eversyn Making high-value glycans mainstream. eversyn is a spin-off of the Max Planck Institute Magdeburg - run, founded and supported by current and former Max Planck scientists and business professionals. Our proprietary technology is based on the efficient use of novel, GMO-free biocatalytic cascades. We have designed and engineered these pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce human milk oligosaccharides and tailor the glycosylation of therapeutic proteins. Synthetic Glycobiotechnology, Glycobiotechnology, Biotechnology, Oligosaccharides, Nucleotide Sugars, In Vitro Glycoengineering, HMOs, and activated sugars Type: | 2 | 0 | 1 | 7 |
 | Libre Foods We work with the brilliance of fungi to reinvent meat as you know it. We are an R&D-driven biotech startup making groundbreaking advancements in fungi-based proteins 🍄 We are commercializing a platform of high-quality fungi-based products starting with our fungi-based Libre Bacon and following with our newest innovation: mycelium-based Libre Chicken. Our mission is to reinvent meat with the power of fungi to empower consumers to make conscious choices for a healthier future. Startup , Scaleup, Fungi-based, Mycelium, Mushroom, Foodtech, Plant-based, Impact, Environment, Food technology, Sustainability, Biotech, Climate-tech, Whole cut meat, Food system, Meat alternatives, Animal welfare, Europe, Barcelona, Diversity, … Type: | 3 | 1 | 3 | 30 |
 | EsoBiotec We Empower Cells In Vivo to Fight Diseases. EsoBiotec is a biotechnology company developing innovative therapeutics to fight cancer. Our mission is to empower the human body to tackle cancer by bringing in vivo engineering of cells to patients. We aim to develop cost-effective and off-the-shelf therapeutics and providing state-of-the-art cell therapies to maximise accessibility. Our disruptive approach holds the potential to transform the current standard of cell and gene therapies for cancer treatment. Gene therapy, Biotechnology, Oncology, Cell therapy, Cancer, in vivo engineering, virology, and Immunology Type: | 1 | 1 | 0 | 15 |
 | Aesyra SA Aesyra SA is a spin-off of EPFL created in November 2017 in close collaboration with medical experts from the Clinique Universitaire de Médecine Dentaire de Genève (CUMD). Aesyra’s mission is to develop, manufacture and commercialize a medical device able to accurately monitor the jaw activity of the patient during sleep and provide an active bio-feedback to reduce teeth grinding without waking-up the patient. Type: | 0 | 0 | 0 | 10 |
 | Hemispherian AS Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer. Hemispherian is a biotechnology company developing new treatments for the most aggressive types of cancer. Our mission is to develop a new drug to treat Glioblastoma Multiforme. We aim to significantly increase life expectancy for patients, improve patient comfort, and generally increase the overall survival rates for GBM patients. cancer treatments, GBM treatments, and therapeutics Type: | 2 | 0 | 1 | 10 |
 | Temple Therapeutics Pioneering a new era in precision medicine for women's health A clinical-stage biotechnology company pioneering a female-focused precision medicine approach using validated biobanks for the discovery, development, and commercialization of novel therapeutics and companion diagnostics in women's health. ovarian cancer, endometrial cancer, fibrosis, endometriosis, post surgical adhesions, surgery, women's health, fitness, health, lifestyle, precision medicine, Artificial Intelligence, Machine Learning, Biobank, gynecology, reproductive medicine, infertility, cervical cancer, pcos, femtech, life sciences, and healthcare Type: | 2 | 0 | 2 | 7 |
 | IRLAB Therapeutics AB A clinical-stage biopharma discovering and developing novel treatments for the most troublesome symptoms of Parkinson's. IRLAB discovers and develops novel treatments of Parkinson’s disease and other CNS disorders. The company's most advanced drug candidates, mesdopetam (IRL790) and pirepemat (IRL752), are in Phase IIb and are designed to treat some of the most difficult symptoms related to Parkinson's . In 2021, Ipsen, a specialty pharma company, acquired exclusive global rights to the development and commercialization of mesdopetam. IRLAB has discovered and generated all its drug candidates and continues to discover innovative drug candidates for the treatment of CNS disorders through its … Type: | 0 | 0 | 0 | 37 |
 | Hoba Therapeutics Developing Restorative Treatments for Chronic Neuropathic Pain and Hearing Loss Hoba Therapeutics is a Danish biotech developing restorative treatments for chronic pain disorders and hearing loss. Both indications have a clear unmet medical need for safe and efficacious treatments for millions of patients worldwide. Hoba Therapeutics is developing HB-086 for the treatment of chronic neuropathic pain. HB-086 is a non-opioid compound with a unique mechanism of action targeting the peripheral nervous system to reverse neuropathic pain and the underlying cause of the disease. The second drug candidate HB-097 is a pharmacological treatment for sensorineural hearing loss. Preclinical data of HB-097 … Type: | 0 | 0 | 0 | 13 |
 | MitoRx Therapeutics Our mission is to arrest the progression of degenerative diseases driven by mitochondrial dysfunction MitoRx Therapeutics is a pre-clinical stage rare disease biotech company aiming to become the leading global developer of medicines arresting the progression of degenerative diseases driven by mitochondrial dysfunction, with a focus on neuromuscular disease, metabolic disease and neurodegenerative disease. mitochondrial disease, rare disease, Duchenne, neuromuscular disease, DMD, biotech, preclinical, drug discovery, mitochondria, new class, MitoRx, MTRX-1, hyperhomocysteinemia, Huntington's, mitochondrial myopathy, muscular dystrophy, neurodegenerative disease, dementia, Huntington's disease, CBS-deficiency, muscular dystrophy, first-in-class, and first-in-target Type: | 1 | 0 | 1 | 13 |
 | ALKemist Bio Next generation cell therapies for ALK-positive cancer patients At ALKemist Bio we are developing TCR-T cells that possess the ability to specifically target ALK antigens found on ALK-positive cancer cells, primarily focusing on non-small cell lung cancer patients. By harnessing the power of the immune system and engineering T cells to precisely recognize and combat these cancerous cells, we aim to pave the way for more effective treatments aiming at improving the standard of care. biotech, immunooncology, oncology, alkpositive, celltherapy, TCR, and ALK Type: | 0 | 0 | 0 | 2 |
 | NutriLeads Delivering plant-based, upcycled, and low-dose precision prebiotic fibers that are clinically proven to improve health. NutriLeads is a pioneering company that is bringing groundbreaking innovation opportunities to the functional food and beverage and supplements industries. As consumers become increasingly health-conscious, the demand for natural and sustainable solutions that provide proven multiple health benefits is increasing. NutriLeads is at the forefront of this development, offering clinically proven, plant-based, precision prebiotic ingredients that enhance human health and well being. Our product portfolio is based on the ground-breaking Rhamnogalacturonan-I (RG-I) technology. RG-I is a structurally complex fiber found in the cell walls of … Type: | 2 | 2 | 0 | 16 |
 | Batavia Biosciences Accelerate Biotechnology Batavia Biosciences is a science-based CDMO that offers personalized services that fully support all the stages of biopharmaceutical development, from cloning to GMP manufacture and release of clinical material for phase I/II studies. We are not your standard CDMO - our customers regularly refer to us as their product development partner and thought partner. We focus on the early stages of product development with services ranging from DNA cloning, mammalian cell line generation, upstream process development, purification development, product characterization to clinical manufacturing. Headquartered in Leiden, The Netherlands, Batavia Biosciences is privileged to have strong strategic partners in … Type: | 1 | 0 | 1 | 201 |
 | REVIV Global REVIV is a global leader in doctor-led preventative health services. Welcome to REVIV - the future of personalized & precision nutritional healthcare! We are on a mission to transform human health through cutting-edge personalized nutritional solutions. With over a decade of IV therapy research, we have unlocked the consumer need for personalized nutrition, and through education we are powering the new era of precision healthcare. Our vision is to revolutionize personalized nutrition and create leading-edge health products backed by science. We aim to democratize the traditional healthcare system by providing access to personalized and precision products and solutions, with innovation … Type: | 0 | 0 | 0 | 141 |
 | TRIANNI, Inc an AbCellera Company Exceptional Human Antibody Discovery Technology Trianni, Inc. is a biotech company specializing in human antibody discovery platform technology. We offer the leading in vivo platform enabling efficient discovery of fully-human monoclonal antibodies. The Trianni Mouse offers biologic drug discoverers a best-in-class solution for the isolation of therapeutic antibody candidates. Benefits over older conventional mouse immunization + humanization approaches include superior lead panels with respect to potency and diversity along with speed to the clinic and lower operating costs. We aim to make Trianni’s premium technology available to any Pharma or Biotech company engaged in antibody discovery by offering flexible licenses … Type: | 0 | 0 | 0 | 1 |
 | Skye Bioscience Inc. Unlocking new therapeutic pathways for metabolic health Skye Bioscience (Nasdaq: SKYE) is focused on unlocking new therapeutic pathways for metabolic health through the development of next-generation molecules that modulate G-protein coupled receptors. Skye's strategy leverages biologic targets with substantial human proof of mechanism for the development of first-in-class therapeutics with clinical and commercial differentiation. Skye plans to start a Phase 2 clinical trial in obesity in Q3 2024 for nimacimab, a negative allosteric modulating antibody that peripherally inhibits CB1, comparing monotherapy and combination arms of nimacimab and a GLP-1R agonist (Wegovy®). Type: | 3 | 2 | 1 | 17 |
 | Generis Tomorrow's Connection Today GENERIS IS A FULL-SERVICE ORGANIZER OF WORLD CLASS BUSINESS SUMMITS We provide leading industry insight, innovative onsite technical and strategic expertise through a platform uniquely designed for executives and professionals to connect. Our experience spans across two decades in successfully developing and delivering high-quality business to business events and services across various industries. Generis was formed with the vision of redefining the way in which knowledge transfer and face to face interactions take place. We see an opportunity to enhance the partnership experience through our understanding of how executives and professionals create and sustain successful relationships. Our … Type: | 91 | 2 | 91 | 115 |
 | Immune Biosolutions inc. Actor of change Immune Biosolutions is a clinical-stage biotechnology company specializing in the discovery and engineering of avian and human antibodies for therapeutic applications. Utilizing cutting-edge technologies, we develop custom immunotherapeutic agents. Our discovery platform efficiently targets complex proteins and generate powerful, specific, and innovative antibodies. Additionally, our antibody production capability allows us to advance our own discovery programs in cancer and autoimmune diseases into the early phases of clinical development. Anticorps, Custom antibody development, Antibody, Développement sur mesure de génération d'anticorps, IgY, Chicken, Poulet, ELISA, Therapeutic Antibodies, Recombinant Antibodies, Humanized Antibodies, GPCRs, and Oncology Type: | 6 | 1 | 1 | 25 |
 | Incuvers Visualize, Connect, and Explore Every Moment of Cellular Research. Incuvers is a hardware + software company developing live cell imaging incubators for cellular researchers. Our flagship product, IRIS (Incuvers Real-time Imaging System) is the most advanced and affordable system for cell culture incubation. Combining hypoxic incubation, live cell imaging, and cloud computing, IRIS lets researchers capture time lapse videos of their entire experiments and monitor them live from anywhere, without ever taking them out of the incubator. The Incuvers mission is to “Visualize, connect, and explore every moment of cellular research”. Type: | 0 | 0 | 0 | 1 |
 | Kenota Health Next generation medical devices. Kenota Health makes allergy testing safe, simple and certain. Kenota Health develops next generation medical diagnostic tools. We make allergy testing safe, simple and certain. Diagnostics, Medical Technology, Point of Care, and Allergy Type: | 0 | 0 | 0 | 29 |
 | Entourage Health Award-winning cannabis brands & products. Crafted with pride, by people who care. Entourage Health Corp. (previously WeedMD Inc.) is the publicly traded parent company of Entourage Brands Corp. (formerly WeedMD RX Inc.) and CannTx Life Sciences Inc., licence holders and producers of cannabis products for both the medical and adult-use markets. The Company owns and operates a 158-acre state-of-the-art greenhouse, outdoor and processing facility located in Strathroy, Ontario as well as a fully-licensed 26,000 sq. ft. Aylmer, Ontario-based extraction, processing and distribution facility. With the addition of Starseed Medicinal, a medical-centric brand, WeedMD has expanded its multi-channeled distribution strategy. Starseed’s … Type: | 1 | 0 | 1 | 126 |
 | Aspect Biosystems Developing bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect Biosystems is a biotechnology company pioneering the development of bioprinted tissue therapeutics to transform the treatment of currently incurable diseases. Aspect is creating these next generation cell therapies by applying its full-stack tissue therapeutic platform, which combines the company’s proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design. Aspect’s bioprinted tissue therapeutics are designed to replace, repair, or supplement biological function inside the body with the aim of treating currently incurable diseases such as type 1 diabetes as well as genetic and acquired liver diseases. bioprinting, tissue … Type: | 10 | 0 | 8 | 109 |
 | eNUVIO - Microfabricated Devices for Next-generation Cell Culture Helping you create human-relevant in vitro models! Imagine a world where your experiments are cutting-edge, yet straightforward to perform, analyze and interpret, experiments that are time-saving, more accurate and more physiologically relevant. All this so you can get results sooner and move closer to your goal. This world is our vision! We’re committed to developing next-generation technologies for you. Powered by scientists, we design and produce innovative microfabricated devices with feature-sized components that match the dimensions of biological cells, so that you can take full advantage of emerging cell culture technologies, such as stem cells & 3D culture systems. These … Type: | 1 | 1 | 0 | 5 |
 | Masimo Corporation Improving life. Improving patient outcomes and reducing the cost of care. Masimo Corporation (NASDAQ: MASI) is a global medical technology company that develops and manufactures innovative non-invasive patient monitoring technologies, including medical devices and a variety of sensors. Our work makes a significant difference in the world by saving, extending and improving the lives of people of all ages in all walks of life. For more than 30 years, our innovative medical technologies and noninvasive patient monitoring solutions have been solving "unsolvable" problems. Our portfolio of clinically validated products provides healthcare providers with the information they need to optimize clinical … Type: | 2 | 1 | 2 | 3 |
 | GestSure The GestSure System allows surgeons to control operating room computers while scrubbed using simple hand gestures. GestSure Technologies is creating rich, touchless gestural interfaces that allow surgeons and interventional radiologists to control the equipment around them. Our system works as a layer on top of existing PACS, 3D visualization, or electronic medical records. That means no clumsy software to install and no need to import imaging into a parallel system. Gestural Interfaces, Medical Devices, and Health IT Type: | 3 | 2 | 2 | 1 |
 | Telo Genomics Genomics Imaging for Precision Medicine Telo Genomics is a biotech company pioneering the most comprehensive telomere platform in the industry with powerful applications and prognostic solutions. These include liquid biopsies and related technologies in oncology and neurological diseases. Liquid biopsy is a rapidly growing field of significant interest to the medical community for being less invasive and more easily replicated than traditional diagnostic approaches. By combining our team’s considerable expertise in quantitative analysis of 3D telomeres with molecular biology and artificial intelligence to recognize disease-associated genetic instability, Telo Genomics is developing simple and accurate products that improve day-to-day care for … Type: | 0 | 0 | 0 | 14 |
 | Vielight Inc. Through neuroscience and engineering, we elevate brain health and performance. Through neuroscience and engineering, we elevate brain health and neural performance with our brain photobiomodulation technology. Published research with our patented technology has produced improvements in cognition, memory and mood. From neurodegeneration to brain performance, we aspire to accelerate photobiomodulation research by collaborating with bright minds globally. neurotechnology, brain photobiomodulation, biohacking, neurofeedback, brain stimulation, wellness technology, alzheimer's research, and traumatic brain injury research Type: | 1 | 1 | 1 | 16 |
 | Intellijoint Surgical Inc. Advancing orthopaedic surgery by providing surgeons with effective, easy-to-use technology. Intellijoint Surgical delivers cutting-edge navigation solutions for total joint replacements, empowering Orthopaedic Surgeons and their Care Teams with user-friendly, effective technologies. Our product suite includes three innovative solutions: * Intellijoint VIEWTM: A web-based planning tool for functional cup planning and implant templating, eliminating the need for CT imaging. * Intellijoint HIP®: Provides real-time, intraoperative measurements for both primary and revision Total Hip Arthroplasty. * Intellijoint KNEE®: Assists with intraoperative measurements, ensuring precise alignment and bony cuts for optimal implant positioning. All our products are supported by robust clinical evidence, enhancing … Type: | 3 | 0 | 3 | 76 |
 | FREDsense Technologies Water quality monitoring powered by biology. FREDsense is a Calgary-based water company looking to solve one of the largest challenges in water today - PFAS. We build portable tools to measure PFAS in real-time and offer analytical testing services for various forms of the compounds. Our lead product - the Field Ready Electrochemical Detector (FRED) - consists of a genetically engineered bacterium tuned to sense various contaminants. The system is portable, autonomous, and connected, providing users with continuous water quality measurements. Synthetic Biology, Water Quality Monitoring, Cleantech, Biotechnology, Sensors, Instrumentation, IoT, PFAS, and Analytical Testing Type: | 0 | 0 | 0 | 24 |
 | Service d’Électro-Thérapie [Automatic translation follows] Relieve your pain. Get back to an active life. Electrotherapy with TENS is scientifically recognized as an effective, safe and complementary solution to medication to control pain. It acts on the body's natural mechanisms through the use of electrodes. Our high-quality devices are designed in Quebec and approved by Health Canada. They are portable and easy to use at home for self-management of pain by patients. We also offer muscle stimulators for healthy muscles and denervated muscles. Our team, composed of members of the Ordre professionnel de la physiothérapie du Québec and specialized in functional electrotherapy, places … Type: | 1 | 1 | 0 | 37 |
 | ELECTRO-MEDIC [Automatic translation follows] Electro-Médic, proud designer of pain-relieving devices accessible to all There are a multitude of daily activities, professional or sporting, and the body reacts in the more or less long term and in a very different way from one individual to another, to each of them. Electro-Médic, proud designer (QC, CA), offers therapeutic devices that are intended for any user wishing to benefit from a program aimed at a significant reduction in pain and even allowing them, depending on the case, to go about their daily activities! The use and benefits of electrotherapy The enthusiasm generated by the … Type: | 1 | 1 | 1 | 3 |
 | Treventis Corporation TREVENTISTM Corporation is dedicated to treating and preventing protein misfolding diseases. We utilize a proprietary, patent-pending discovery engine – Common Conformational Morphology (CCM) – to identify druggable active sites in misfolded protein targets. CCM combines unique in silico models with deep expertise in model development (in vitro, ex vivo, in vivo) to enable rational drug design against misfolded protein targets. Our lead program focuses on anti-misfolding small molecules in tauopathy (3R, 4R, familial mutations and mixed) with relevance to Alzheimer’s disease. We have further CCM-driven efforts in oncology and other neurodegenerative diseases that show the wide utility of our technology … Type: | 1 | 1 | 0 | 16 |
 | MediPharm Labs MediPharm Labs was created in 2015 by a handful of industry experts in Ontario. With the medicinal benefits of cannabis firmly established – and with a global patient market demanding quality cannabis oil – MediPharm Labs was born. While initially exploring options to cultivate cannabis plant, MediPharm Labs came to recognize the opportunity for a select focus on cannabis concentrates. MediPharm Labs set out to master this area of production, and rely on the many cultivating experts to provide quality raw materials. In 2016, MediPharm labs submitted an application to Health Canada for approval to distribute medicinal cannabis oil. Proudly, … Type: | 0 | 0 | 0 | 147 |
 | MaSTherCell Now a part of Catalent Cell & Gene Therapy With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus (AAV) and lentiviral vectors, and CAR-T immunotherapies. When it acquired MaSTherCell, Catalent added expertise in autologous and allogeneic cell therapy development and manufacturing to position it as a premier technology, development and manufacturing partner for innovators across the entire field of advanced biotherapeutics. Catalent has a global cell and gene therapy network of dedicated, large-scale clinical and commercial manufacturing facilities, and fill-finish and packaging capabilities located in both the U.S. … Type: | 1 | 1 | 1 | 26 |
 | MSD España [Automatic translation follows] We invent for life! At Merck & Co., Inc. in the United States and Canada, with headquarters in Rahway, New Jersey, we are united by our purpose of harnessing the power of science to save and improve lives around the world. For more than 130 years, we have delivered hope through the development of important medicines and vaccines. We aspire to be the world's leading research-based biopharmaceutical company, and today we are at the forefront of research into innovative health solutions to advance the prevention and treatment of human and animal diseases. We foster a diverse and … Type: | 8 | 2 | 2 | 406 |
Startup